The "Tides" Have Changed: Outsourcing Oligos And Peptides
Source: Outsourced Pharma
Shifting demand for oligos and peptides drove innovation in CDMO partnerships and reshaped outsourcing relationships. In this Outsourced Pharma Live panel, industry experts shared best practices for outsourcing these specialized therapeutics, with a focus on capacity, regulatory challenges, and technology transfer.
        access the Virtual Event!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
             
        
        
            Case Studies & White Papers
             
        
        
            Extensive Product Database
             
        
        
            Members-Only Premium Content
             
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
        Subscribe to Advancing RNA
        X
    
    
        Subscribe to Advancing RNA
    
    